4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-021261
Director acquired 2,377 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Molineaux Christopher P. · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-20 | Exercise or conversion : show line 1 in the form | +1,993 | $0.41 | $817 | 9,598 | D |
| 2018-03-20 | Exercise or conversion : show line 2 in the form | +120 | $0.72 | $86 | 9,718 | D |
| 2018-03-20 | Exercise or conversion : show line 3 in the form | +264 | $1.52 | $401 | 9,982 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-20 | Exercise or conversion : show line 4 in the form Stock option (right to buy) | −1,993 | 0 | D |
| 2018-03-20 | Exercise or conversion : show line 5 in the form Stock option (right to buy) | −120 | 51 | D |
| 2018-03-20 | Exercise or conversion : show line 6 in the form Stock option (right to buy) | −264 | 198 | D |
Loading xslF345X03/doc4.xml…